×
The Standard e-Paper
Informed Minds Prefer The Standard
The CDC says the measures are intended "to reduce the risk of Ebola importation into the United States.
Scientists have launched the first clinical trial to test whether an experimental antiviral pill can prevent Bundibugyo Ebola after exposure, offering hope for a new outbreak-control tool.
The World Health Organization (WHO) has added the world's first molecular diagnostic test for the Bundibugyo strain of Ebola virus to its Emergency Use Listing (EUL).
An international clinical trial has begun enrolling patients in the Democratic Republic of the Congo (DRC) in a step towards identifying the first effective treatment for Bundibugyo.
Gavi and CEPI have launched a $40 million initiative to fast-track a trial-ready vaccine for the Bundibugyo Ebola strain before future outbreaks occur.
Subscribe to our newsletter and stay updated on the latest developments and special offers!
Join